NELSON ANDINO RIOS: Open Payments
NPI 1851760060 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 51 payments from 9 companies in 2025. Trend: 2023 $1,647 · 2024 $1,262 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 13 | $174 |
| Otsuka America Pharmaceutical, Inc. | 7 | $157 |
| ABBVIE INC. | 17 | $150 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| Lundbeck LLC | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Indivior Inc. | 1 | $28 |
Products named: ARISTADA, VRAYLAR, ABILIFY MAINTENA, REXULTI, COBENFY, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
